- Venture Partner, OurCrowd
- Dr. Morris Laster is a healthcare executive/entrepreneur with over 25 years of experience in the biopharmaceutical industry. His expertise lies in the identification, development, management and financing of advanced biomedical drugs and technologies. Currently, Morris is the Venture Partner responsible for Medtech investments at OurCrowd (www.ourcrowd.com) a world leading crowd funding platform. He has invented a novel vascular access device under development at the Rad-Biomed Incubator in Tel Aviv. He has founded 6 companies that have gone public in the US, UK and Israel. He was a co-founder and CEO of Kitov Pharmaceuticals that recently completed a successful Phase 3 trial. Previously, (2003-2009) he was the founding CEO of BioLineRx Ltd. (TASE:BLRX). From 1997-2002 he was the Chairman and CEO of Keryx Biopharmaceuticals (NASDAQ:KERX). He began his career as a VP of medical venture capital at Paramount Capital in NYC. He received his MD from Downstate Medical Center, Brooklyn, NY in 1990 and a BS in Biology from SUNY Albany.